170 related articles for article (PubMed ID: 32184664)
1. Sal-Like Protein 4 Transcription Factor: A Significant Diagnostic Biomarker Involved in Childhood ALL Resistance and Relapse.
Ohadi F; Rahgozar S; Ghodousi ES
Cancer Manag Res; 2020; 12():1611-1619. PubMed ID: 32184664
[TBL] [Abstract][Full Text] [Related]
2. SALL4, a stem cell factor, affects the side population by regulation of the ATP-binding cassette drug transport genes.
Jeong HW; Cui W; Yang Y; Lu J; He J; Li A; Song D; Guo Y; Liu BH; Chai L
PLoS One; 2011 Apr; 6(4):e18372. PubMed ID: 21526180
[TBL] [Abstract][Full Text] [Related]
3. miR-324-3p and miR-508-5p expression levels could serve as potential diagnostic and multidrug-resistant biomarkers in childhood acute lymphoblastic leukemia.
Zamani A; Fattahi Dolatabadi N; Houshmand M; Nabavizadeh N
Leuk Res; 2021 Oct; 109():106643. PubMed ID: 34147937
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of miR-335-3p, targeted by NEAT1 and MALAT1 long non-coding RNAs, is associated with poor prognosis in childhood acute lymphoblastic leukemia.
Pouyanrad S; Rahgozar S; Ghodousi ES
Gene; 2019 Apr; 692():35-43. PubMed ID: 30639603
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-326 and microRNA-200c: Two novel biomarkers for diagnosis and prognosis of pediatric acute lymphoblastic leukemia.
Ghodousi ES; Rahgozar S
J Cell Biochem; 2018 Jul; 119(7):6024-6032. PubMed ID: 29630744
[TBL] [Abstract][Full Text] [Related]
6. The translational expression of ABCA2 and ABCA3 is a strong prognostic biomarker for multidrug resistance in pediatric acute lymphoblastic leukemia.
Aberuyi N; Rahgozar S; Khosravi Dehaghi Z; Moafi A; Masotti A; Paolini A
Onco Targets Ther; 2017; 10():3373-3380. PubMed ID: 28744141
[TBL] [Abstract][Full Text] [Related]
7. Acute lymphoblastic leukemia in children and SALL4 and BMI-1 gene expression.
Hodeib H; El Amrousy D; Youssef A; Khedr R; Al-Asy H; Shabana A; Elnemr S; Abdelhai D
Pediatr Res; 2023 Oct; 94(4):1510-1515. PubMed ID: 34782707
[TBL] [Abstract][Full Text] [Related]
8. mRNA expression profile of multidrug-resistant genes in acute lymphoblastic leukemia of children, a prognostic value for ABCA3 and ABCA2.
Rahgozar S; Moafi A; Abedi M; Entezar-E-Ghaem M; Moshtaghian J; Ghaedi K; Esmaeili A; Montazeri F
Cancer Biol Ther; 2014 Jan; 15(1):35-41. PubMed ID: 24145140
[TBL] [Abstract][Full Text] [Related]
9. The Hedgehog signal transducer
Sheybani Z; Rahgozar S; Ghodousi ES
Cancer Manag Res; 2019; 11():7621-7630. PubMed ID: 31616178
[TBL] [Abstract][Full Text] [Related]
10. The differential expression pattern of the BMI-1, SALL4 and ABCA3 genes in myeloid leukemia.
Shen Q; Liu S; Hu J; Chen S; Yang L; Li B; Wu X; Ma Y; Yang J; Ma Y; Li Y
Cancer Cell Int; 2012 Oct; 12(1):42. PubMed ID: 23067006
[TBL] [Abstract][Full Text] [Related]
11. Tyrosinekinase inhibition facilitates cooperation of transcription factor SALL4 and ABC transporter A3 towards intrinsic CML cell drug resistance.
Hupfeld T; Chapuy B; Schrader V; Beutler M; Veltkamp C; Koch R; Cameron S; Aung T; Haase D; Larosee P; Truemper L; Wulf GG
Br J Haematol; 2013 Apr; 161(2):204-13. PubMed ID: 23432194
[TBL] [Abstract][Full Text] [Related]
12. [Detection of SALL4 mRNA expression in leukemia by real-time fluorescent quantitative PCR].
Duan MX; Bi CX; Chen H; Wang N; Li SJ; Xiao XG; Ma XL; Yuan H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1153-6. PubMed ID: 24156424
[TBL] [Abstract][Full Text] [Related]
13. [Expression of SALL4 and BMI-1 mRNA in acute leukemia].
Tang P; Sun H; Liu YF; Wang GY; Yin YF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1271-4. PubMed ID: 19099625
[TBL] [Abstract][Full Text] [Related]
14. The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma.
Zeng SS; Yamashita T; Kondo M; Nio K; Hayashi T; Hara Y; Nomura Y; Yoshida M; Hayashi T; Oishi N; Ikeda H; Honda M; Kaneko S
J Hepatol; 2014 Jan; 60(1):127-34. PubMed ID: 24012616
[TBL] [Abstract][Full Text] [Related]
15. The new advance of SALL4 in cancer: Function, regulation, and implication.
Abouelnazar FA; Zhang X; Wang M; Zhang J; Yu D; Zang X; Zhang J; Li Y; Xu J; Yang Q; Zhou Y; Tang H; Wang Y; Gu J; Zhang X
J Clin Lab Anal; 2023 May; 37(9-10):e24927. PubMed ID: 37337914
[TBL] [Abstract][Full Text] [Related]
16. Comparison of minimal residual disease (MRD) monitoring by WT1 quantification between childhood acute myeloid leukemia and acute lymphoblastic leukemia.
Zhang R; Yang JY; Sun HQ; Jia H; Liao J; Shi YJ; Li G
Eur Rev Med Pharmacol Sci; 2015; 19(14):2679-88. PubMed ID: 26221900
[TBL] [Abstract][Full Text] [Related]
17. Sall4 overexpression blocks murine hematopoiesis in a dose-dependent manner.
Milanovich S; Peterson J; Allred J; Stelloh C; Rajasekaran K; Fisher J; Duncan SA; Malarkannan S; Rao S
Exp Hematol; 2015 Jan; 43(1):53-64.e1-8. PubMed ID: 25246269
[TBL] [Abstract][Full Text] [Related]
18. [A tal-1 deletion as real-time quantitative polymerase chain reaction target for detection of minimal residual disease in T-lineage acute lymphoblastic leukemia].
Wang L; Zhang LP; Li ZG; Cheng YF; Tian KG; Lu AD
Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):170-3. PubMed ID: 15833185
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous changes in expression levels of BAALC and miR-326: a novel prognostic biomarker for childhood ALL.
Ghodousi ES; Aberuyi N; Rahgozar S
Jpn J Clin Oncol; 2020 Jun; 50(6):671-678. PubMed ID: 32129446
[TBL] [Abstract][Full Text] [Related]
20. Expression pattern and prognostic implication of SALL4 gene in myeloid leukemias: a case-control study.
Farawela HM; Zawam HM; Al-Wakeel HA; El-Nagdy MH; El-Refaey FA; Abdel-Rahman HA
Scand J Clin Lab Invest; 2019; 79(1-2):65-70. PubMed ID: 30638095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
